| Income Statement | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Sales, net | 665,915 | 644,181 | ||
| Cost of sales | 454,486 | 433,024 | ||
| Gross profit | 211,429 | 211,157 | ||
| Research and development | 11,284 | 12,439 | ||
| (gain) loss on divestitures, net (note 7) | -872 | 19,659 | ||
| Selling, general, and administrative | 133,548 | 137,349 | ||
| Operating income | 65,725 | 81,028 | ||
| Other income (expense), net (note 4) | 255 | -77 | ||
| Interest expense, net | -8,237 | -9,421 | ||
| Income before income taxes | 57,743 | 71,530 | ||
| Income tax provision | 15,945 | 14,410 | ||
| Net income | 41,798 | 57,120 | ||
| Reclassification of net actuarial loss for pension and postretirement benefit plans recorded to net income, net of tax (expense) of (178) and (357) for the three and six months ended september 30, 2024, respectively, and (176) and (352) for the three and six months ended september 24, 2023, respectively | -565 | -565 | ||
| Change in derivative instruments, net of tax benefit (expense) of 510 and 312 for the three and six months ended september 30, 2024, respectively, and (657) and (1,150) for the three and six months ended september 24, 2023, respectively | -1,617 | 628 | ||
| Change in cumulative translation adjustment, net of tax benefit (expense) of 0 and 0 for the three and six months ended september 30, 2024, respectively, and 0 and 0 for the three and six months ended september 24, 2023, respectively | 1,002 | -249 | ||
| Total other comprehensive (loss) income | -50 | 944 | ||
| Comprehensive income | 41,748 | 58,064 | ||
| Basic eps | 0.72 | 0.98 | ||
| Diluted eps | 0.71 | 0.97 | ||
| Basic average shares | 58,410,000 | 58,312,000 | ||
| Diluted average shares | 58,786,000 | 58,641,000 | ||
null (VSTO)
null (VSTO)